SERMs [horm, phsu]
Current [tmco]
Status [qlco]
Future [tmco]
trends [tmco]
Selective Estrogen Receptor Modulators [horm, phsu]
SERMs [horm, phsu]
Class [inpr]
Compound [qlco]
ACT [topp]
Estrogen Receptor Agonists [moft]
Tissues [tisu]
ACT [topp]
Estrogen Receptor Antagonists [moft]
Others [fndg]
SERMs [horm, phsu]
Evaluated [ftcn]
To [qlco]
TREAT [ftcn]
PREVENT [phsu]
Diseases [dsyn]
Breast Cancer [neop]
Osteoporosis [dsyn]
Cardiovascular disease [dsyn]
Currently [tmco]
Three [qnco]
Primary [qlco]
SERMs [horm, phsu]
Tamoxifen [orch, phsu]
Toremifene [orch, phsu]
triphenylethylene [orch, phsu]
Raloxifene [orch, phsu]
benzothiophene [orch]
Tamoxifen [orch, phsu]
Toremifene [orch, phsu]
effects [qlco]
Oil [lipd]
Bone [bpoc]
Serum lipids NOS [lbpr]
Currently [tmco]
To [qlco]
TREAT [ftcn]
Breast Cancer [neop]
effects [qlco]
Uterus [bpoc]
Raloxifene [orch, phsu]
Indicated [fndg]
treatment [ftcn]
Prevention [topp]
Osteoporosis [dsyn]
effects [qlco]
Bone [bpoc]
Serum lipids NOS [lbpr]
Not [ftcn]
Uterus [bpoc]
Three [qnco]
Associated [qlco]
Venous Thromboembolism [patf]
Hot Flashes [sosy]
New [tmco]
SERMs [horm, phsu]
TREAT [ftcn]
PREVENT [phsu]
Breast Cancer [neop]
Osteoporosis [dsyn]
Cardiovascular disease [dsyn]
Clinical [qlco]
development [phsf]
Including [ftcn]
idoxifene [orch, phsu]
droloxifene [orch, phsu]
Ospemifene [orch, phsu]
Lasofoxifene [orch, phsu]
arzoxifene [orch, phsu]
[c] [qnco]
Science [ocdi]
Ireland [geoa]
LTD [ortf]
Rights [qlco]
Reserve [acty]
